Inhibrx Stock Odds of Future Stock Price Finishing Under 14.09
| INBX Stock | USD 14.49 0.02 0.14% |
Inhibrx |
Inhibrx Target Price Odds to finish below 14.09
The tendency of Inhibrx Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to drop to $ 14.09 or more in 90 days |
| 14.49 | 90 days | 14.09 | nearly 4.67 |
Based on a normal probability distribution, the odds of Inhibrx to drop to $ 14.09 or more in 90 days from now is nearly 4.67 (This Inhibrx probability density function shows the probability of Inhibrx Stock to fall within a particular range of prices over 90 days) . Probability of Inhibrx price to stay between $ 14.09 and its current price of $14.49 at the end of the 90-day period is about 8.83 .
Given the investment horizon of 90 days Inhibrx has a beta of 0.89. This usually indicates Inhibrx market returns are sensitive to returns on the market. As the market goes up or down, Inhibrx is expected to follow. Additionally Inhibrx has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Inhibrx Price Density |
| Price |
Predictive Modules for Inhibrx
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Inhibrx. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Inhibrx Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Inhibrx is not an exception. The market had few large corrections towards the Inhibrx's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Inhibrx, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Inhibrx within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.13 | |
β | Beta against Dow Jones | 0.89 | |
σ | Overall volatility | 0.70 | |
Ir | Information ratio | -0.05 |
Inhibrx Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Inhibrx for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Inhibrx can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Inhibrx generated a negative expected return over the last 90 days | |
| Inhibrx has a very high chance of going through financial distress in the upcoming years | |
| Inhibrx was previously known as INXB Old and was traded on NASDAQ Exchange under the symbol INXB. | |
| The company reported the previous year's revenue of 1.8 M. Net Loss for the year was (241.36 M) with loss before overhead, payroll, taxes, and interest of (107.99 M). | |
| Inhibrx currently holds about 176.38 M in cash with (193.31 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.52. | |
| Inhibrx has a frail financial position based on the latest SEC disclosures | |
| Roughly 67.0% of the company shares are owned by institutional investors | |
| Latest headline from investing.com: Inhibrxs SWOT analysis biotech stock faces pivotal year amid clinical trials |
Inhibrx Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Inhibrx Stock often depends not only on the future outlook of the current and potential Inhibrx's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Inhibrx's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 47.1 M | |
| Cash And Short Term Investments | 277.9 M |
Inhibrx Technical Analysis
Inhibrx's future price can be derived by breaking down and analyzing its technical indicators over time. Inhibrx Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Inhibrx. In general, you should focus on analyzing Inhibrx Stock price patterns and their correlations with different microeconomic environments and drivers.
Inhibrx Predictive Forecast Models
Inhibrx's time-series forecasting models is one of many Inhibrx's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Inhibrx's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Inhibrx
Checking the ongoing alerts about Inhibrx for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Inhibrx help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Inhibrx generated a negative expected return over the last 90 days | |
| Inhibrx has a very high chance of going through financial distress in the upcoming years | |
| Inhibrx was previously known as INXB Old and was traded on NASDAQ Exchange under the symbol INXB. | |
| The company reported the previous year's revenue of 1.8 M. Net Loss for the year was (241.36 M) with loss before overhead, payroll, taxes, and interest of (107.99 M). | |
| Inhibrx currently holds about 176.38 M in cash with (193.31 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.52. | |
| Inhibrx has a frail financial position based on the latest SEC disclosures | |
| Roughly 67.0% of the company shares are owned by institutional investors | |
| Latest headline from investing.com: Inhibrxs SWOT analysis biotech stock faces pivotal year amid clinical trials |
Additional Tools for Inhibrx Stock Analysis
When running Inhibrx's price analysis, check to measure Inhibrx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inhibrx is operating at the current time. Most of Inhibrx's value examination focuses on studying past and present price action to predict the probability of Inhibrx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inhibrx's price. Additionally, you may evaluate how the addition of Inhibrx to your portfolios can decrease your overall portfolio volatility.